Rhelion adds Canadian patent covering psilocybin extraction and composition
Rhelion said its subsidiary Filament Health received a new Canadian patent covering extraction and composition with controlled dephosphorylation, extending its natural psilocybin IP estate to 78 issued patents across 13 families.